Enhancing Survival for Patients with Pleural Mesothelioma: A Multimodal Treatment Approach
|

Enhancing Survival for Patients with Pleural Mesothelioma: A Multimodal Treatment Approach

ByHolly Zink

Malignant pleural mesothelioma poses a significant health challenge. Linked to asbestos exposure, this aggressive cancer demands innovative treatment strategies. Recent research provides a promising approach to combatting mesothelioma. This multimodal treatment regimen could offer hope and improved outcomes for individuals battling this disease. A multimodal approach is when multiple treatments are used together. It is the most reliable way to improve survival in patients with malignant pleural mesothelioma. Understanding Pleural Mesothelioma Malignant pleural mesothelioma is an aggressive cancer. It is diagnosed late, which often presents unique challenges. While recent advancements like immunotherapy have emerged, survival rates remain low for patients. A new study focused on cytoreductive surgery combined with hyperthermic intrathoracic chemoperfusion (HITOC). This is a multimodal approach to mesothelioma…

Surgical Intervention in Pleural Mesothelioma: A Key to Improved Survival

Surgical Intervention in Pleural Mesothelioma: A Key to Improved Survival

ByHolly Zink

Pleural mesothelioma is a rare, aggressive cancer with a poor prognosis. The impact of surgery on mesothelioma patient survival is unclear and sparking debate. A recent study was presented at the World Conference on Lung Cancer. It checked the survival of pleural mesothelioma. Some patients had chemotherapy treatments followed by surgery, while other patients skipped surgery. The aim of the study was to see if surgery could help mesothelioma patients live longer. The Impact of Surgery on Survival There are a variety of surgical procedures and treatments for pleural mesothelioma. The most recent study, from January 2011 to December 2021, included 296 patients. All were eligible for surgery after three cycles of chemotherapy with platinum plus pemetrexed. Among them, 272 had the…

Hemithoracic Radiotherapy for Mesothelioma
| | | |

Hemithoracic Radiotherapy for Mesothelioma

ByHolly Zink

A type of radiation therapy called hemithoracic radiotherapy could be safely used as part of the treatment plan for patients with malignant pleural mesothelioma (MPM). Malignant pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers the lungs and chest wall. This cancer is caused by exposure to asbestos. Pleural mesothelioma occurs in about 2,000 people in the United States every year. Diagnosis typically occurs in people over the age of 60, but pleural mesothelioma has occurred in people in their twenties. Surgery, Chemotherapy and Radiation A study conducted in Turkey looked at 11 patients with mesothelioma who received multimodal therapy. This type of treatment plan uses more than one type of therapy…

Hemithoracic Radiotherapy for Mesothelioma
| | | |

Hemithoracic Radiotherapy for Mesothelioma

ByHolly Zink

A type of radiation therapy called hemithoracic radiotherapy could be safely used as part of the treatment plan for patients with malignant pleural mesothelioma (MPM). Malignant pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers the lungs and chest wall. This cancer is caused by exposure to asbestos. Pleural mesothelioma occurs in about 2,000 people in the United States every year. Diagnosis typically occurs in people over the age of 60, but pleural mesothelioma has occurred in people in their twenties. Surgery, Chemotherapy and Radiation A study conducted in Turkey looked at 11 patients with mesothelioma who received multimodal therapy. This type of treatment plan uses more than one type of therapy…

Less Invasive Multimodal Treatment for Mesothelioma
|

Less Invasive Multimodal Treatment for Mesothelioma

ByHolly Zink

A less invasive multimodal treatment for mesothelioma can lead to better survival. A team of German researchers discovered this after looking at 20 years of patient data. Mesothelioma is a rare form of cancer. It most often appears in older adults and is caused by exposure to asbestos. Asbestos is a toxic material that can be found in industrial and consumer products. Malignant pleural mesothelioma is a specific type of mesothelioma. It develops in the thin layer of tissue that covers the lungs and chest wall. Malignant pleural mesothelioma has three main subtypes: epithelioid, sarcomatoid, and mixed. Mesothelioma is also an aggressive cancer. It can be hard to treat because symptoms may not show up until decades after the asbestos…

The Link Between Surgery and Radiotherapy for Mesothelioma
| | |

The Link Between Surgery and Radiotherapy for Mesothelioma

ByHolly Zink

A study from the Journal of Clinical Oncology has reviewed the link between radiotherapy and surgery. This is exciting new research in mesothelioma treatment. The study was conducted by mesothelioma experts in Australia. Malignant mesothelioma is a rare and aggressive cancer that rarely responds to a single cancer therapy. Malignant mesothelioma is almost always caused by exposure to asbestos. Usually, that happens in the workplace. Exciting New Research There is ongoing research exploring surgical options for mesothelioma. There are two common surgical procedures for mesothelioma: extrapleural pneumonectomy and pleurectomy decortication. Extrapleural pneumonectomy involves removing the lung affected by mesothelioma. Part of the diaphragm and the linings of the lung and heart are also removed. Pleurectomy decortication is a two-part surgical…

Surgery-Based Multimodal Treatment Improves Survival for Italian Mesothelioma Patients
| | | |

Surgery-Based Multimodal Treatment Improves Survival for Italian Mesothelioma Patients

ByAlex Strauss

A new Italian report suggests that a surgery-based multimodal treatment approach to mesothelioma can help patients live longer with few serious side effects.  The new study comes from Careggi University Hospital in Florence. Thoracic oncologists tracked the outcomes of 12 of their mesothelioma patients since 2017. All of the patients had early-stage pleural mesothelioma of the epithelioid subtype. Results showed that none of them died within the first year after surgery-based multimodal treatment. More than half lived for at least three years.  These are considered very positive results for a cancer that often claims lives within months of diagnosis.  Understanding Surgery-Based Multimodal Treatment Some types of cancer can be successfully treated with just one type of therapy. Pleural mesothelioma is…